News

Enter your email address to get Core One Labs News Alerts.

News

Enter your email address to get Core One Labs News Alerts.
Company News
August 23, 2023
Core One Labs Commends Study Exploring Psychedelics’ Efficacy in Providing Relief for Chronic Pain Conditions
Vancouver, British Columbia, Canada – August 23, 2023 – Core One Labs Inc. (CSE: COOL), (OTCQB: CLABF), (Frankfurt: LD6,...
Read more
Company News
August 04, 2023
Core One’s Akome Reveals Groundbreaking Positive Results from its Second Round of Stage 1 Animal Model Studies for Bio-Compounds Targeting Alzheimer’s and Parkinson’s Disease
Vancouver, British Columbia, Canada – August 4, 2023 – Core One Labs Inc. (CSE: COOL) (OTCQB: CLABF) (Frankfurt: LD6, WKN: A3CSSU), (the “Company”...
Read more
Company News
August 03, 2023
Core One Labs Applauds Groundbreaking Research on Psilocybin as a Potential Anorexia Treatment
Vancouver, British Columbia, Canada – August 3, 2023 – Core One Labs Inc. (CSE: COOL), (OTCQB: CLABF), (Frankfurt: LD6,...
Read more
Company News
August 01, 2023
Core One Labs’, Awakened Biosciences, Announces Groundbreaking Step Forward in Isolating and Purifying Psilocybin from Mushroom Biomass
Core One’s Wholly-Owned Subsidiary has filed a patent application with the United States Patent and Trademark Office Vancouver, British Columbia, Canada – August 1,...
Read more
Company News
July 28, 2023
Core One’s Akome Receives Positive Preliminary Stage 1 Animal Model Study Results for Bio-Compound Targeting Alzheimer’s and Parkinson’s Disease
Vancouver, British Columbia, Canada – July 28, 2023 – Core One Labs Inc. (CSE: COOL), (OTCQB: CLABF), (Frankfurt: LD6, WKN: A3CSSU) (the...
Read more
Company News
July 21, 2023
Core One Labs Enters into Letter of Intent for First Sale of its Psychedelic Compounds
Vancouver, British Columbia, Canada – July 21, 2023 – Core One Labs Inc. (CSE: COOL), (OTCQB: CLABF), (Frankfurt: LD6,...
Read more